AKT1 and cancer: Apart from the aforementioned two pathways, m6A influences the pathogenesis and progression of cancer through additional classical pathways, such as p53, EMT, mitogenactivated protein kinase (MAPK), PI3K/AKT/mammalian target of rapamycin (mTOR), and p38/extracellular signalregulated kinase (ERK).